GLP-1 receptor agonists × glycemic control

TrialDiabetes care2014

Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.

Michaela Diamant et al.PubMed ↗Publisher ↗

What the trial testedas reported · 1,137 people · 2014

Range includes no effect

No clear effect on glycemic control

−0.04−0.18 to +0.11

As reported

difference −0.04, 95% CI −0.18 to 0.11

One number in the abstract

the abstract, start to end

treatment differences were -0.04 (95% CI -0.18, 0.11) in

← favours treatmentfavours comparator →
could be chance
Glycemic control
−0.04−0.18 to 0.11
GLP-1 receptor agonistsInsulinGlycemic control
1 / 3

74 papers cite itlatest 60 shown

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2025
2026
this paperpooled ittrialcites it

4 trials

Full record →Abstract, authors, funding and every citing paper · PMID 25011946